Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.100
-0.070 (-3.23%)
Dec 20, 2024, 4:00 PM EST - Market closed

Entera Bio Revenue

Entera Bio had revenue of $42.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $99.00K, up 607.14% year-over-year.

Revenue (ttm)
$99.00K
Revenue Growth
+607.14%
P/S Ratio
n/a
Revenue / Employee
$5,500
Employees
18
Market Cap
77.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022134.00K-437.00K-76.53%
Dec 31, 2021571.00K206.00K56.44%
Dec 31, 2020365.00K129.00K54.66%
Dec 31, 2019236.00K-264.00K-52.80%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 212.14M
23andMe Holding Co. 193.26M
Karyopharm Therapeutics 148.44M
Assertio Holdings 125.76M
EDAP TMS 70.72M
InspireMD 6.82M
Adlai Nortye 5.00M
Ikena Oncology 659.00K
Revenue Rankings